Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$5,739,239
-$426,228 QoQ
Shares Held
15,849
-9.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#771
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Jun 30, 2025CallValue
$27,921
CallShares
100
PutValue
$50
PutShares
100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prime Capital Investment Advisors, LLC holds $167,982,283 across 14 Drug Manufacturers - General names. AMGN ranks #4 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
63,152 | $75,746,409 | |
| 2 | ABBV |
AbbVie Inc.
|
128,509 | $32,338,004 | |
| 3 | JNJ |
Johnson & Johnson
|
127,237 | $32,314,380 | |
| 4 | AMGN |
Amgen Inc
This page
|
15,849 | $5,739,239 | |
| 5 | MRK |
Merck & Co., Inc.
|
43,565 | $5,598,102 | |
| 6 | PFE |
Pfizer Inc
|
113,165 | $2,725,013 | |
| 7 | NVO |
Novo Nordisk A S
|
56,457 | $2,706,548 | |
| 8 | NVS |
Novartis AG
|
16,577 | $2,597,947 |
All Filings in AMGN
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,739,239 | 15,849 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $6,165,467 | 17,523 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $6,322,974 | 19,318 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $4,404,295 | 15,607 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $50 | 100 | Put | Sole | 2025-07-23 | |
| 2025-06-30 | $5,009,306 | 17,941 | Shares | Sole | 2025-07-23 | |
| 2025-06-30 | $27,921 | 100 | Call | Sole | 2025-07-23 | |
| 2025-03-31 | $700 | 100 | Put | Sole | 2025-05-13 | |
| 2025-03-31 | $8,258,567 | 26,508 | Shares | Sole | 2025-05-13 | |
| 2025-03-31 | $211 | 100 | Call | Sole | 2025-05-13 | |
| 2024-12-31 | $11,736,097 | 45,028 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $15,601,730 | 48,421 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $14,670,777 | 46,954 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $15,364,084 | 54,038 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $13,170,290 | 45,727 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $10,439,175 | 38,842 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $8,316,869 | 37,460 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $9,812,149 | 40,588 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $6,840,458 | 26,045 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $442,234 | 1,962 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $346,702 | 1,425 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $288,974 | 1,195 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $268,839 | 1,195 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $222,644 | 1,047 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $401,943 | 1,649 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $205,517 | 826 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $261,878 | 1,139 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $202,311 | 796 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $194,348 | 824 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $245,911 | 1,213 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||